Xenon Pharmaceuticals Inc XENE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
43.05UNCH (UNCH)
Volume
58,220
Close
43.05UNCH (UNCH)
Volume
306,046
52 week range
27.99 - 50.99
Loading...
  • Open42.88
  • Day High43.54
  • Day Low42.38
  • Prev Close43.00
  • 52 Week High50.99
  • 52 Week High Date03/01/24
  • 52 Week Low27.99
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap3.247B
  • Shares Out75.43M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change-6.53

KEY STATS

  • Open42.88
  • Day High43.54
  • Day Low42.38
  • Prev Close43.00
  • 52 Week High50.99
  • 52 Week High Date03/01/24
  • 52 Week Low27.99
  • 52 Week Low Date11/13/23
  • Market Cap3.247B
  • Shares Out75.43M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change-6.53

RATIOS/PROFITABILITY

  • EPS (TTM)-2.73
  • P/E (TTM)-15.77
  • Fwd P/E (NTM)-14.95
  • EBITDA (TTM)-210.513M
  • ROE (TTM)-22.12%
  • Revenue (TTM)-
  • Gross Margin (TTM)12.82%
  • Net Margin (TTM)-124,040.10%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Xenon Pharmaceuticals Inc

 

Profile

MORE
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the...
Simon Pimstone Ph.D.
Chairman of the Board
Ian Mortimer CPA
President, Chief Executive Officer, Director
Sherry Aulin CPA
Chief Financial Officer
James Empfield Ph.D.
Executive Vice President - Drug Discovery
Robin Sherrington Ph.D.
Executive Vice President - Strategy and Innovation
Address
3650 Gilmore Way
Vancouver, BC
V5G 4W8
Canada

Top Peers

SYMBOLLASTCHG%CHG
CRNX
Crinetics Pharmaceuticals Inc
46.81UNCHUNCH
MLTX
MoonLake Immunotherapeutics
50.23UNCHUNCH
IDYA
IDEAYA Biosciences Inc
43.88UNCHUNCH
SWTX
SpringWorks Therapeutics Inc
49.22UNCHUNCH
IBRX
Immunitybio Inc
5.37UNCHUNCH